Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02398149 · ClinicalTrials.gov registry record
Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis
A clinical trial of Multiple Sclerosis, sponsored by Mount Sinai Rehabilitation Hospital.
- Completed
- Registry status
- 267
- Enrollment target
- 1
- Study location
NCT02398149 is a study of Multiple Sclerosis that has completed, run by Mount Sinai Rehabilitation Hospital. The registered enrollment target is 267 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02398149, a study of Multiple Sclerosis, has completed, sponsored by Mount Sinai Rehabilitation Hospital.
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
- 1
- Study location
Study Summary
Upper extremity (UE) function is critical to maintaining independence. Better understanding of UE involvement in MS will provide necessary information to prioritize the design and selection of future interventions. The goal of the proposed project is to characterize UE involvement in a population of community-based persons with MS across the International Classification of Functioning, Disability \& Health (ICF) domains and constructs.
Conditions Studied
Study Locations (1)
Connecticut
- Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02398149
The ClinicalTrials.gov registry entry for NCT02398149 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (54% lower). The listed sponsor is Mount Sinai Rehabilitation Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT02398149 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02398149 about?
NCT02398149 is a clinical study titled "Characterizing Upper Extremity Function in Individuals With Multiple Sclerosis". Upper extremity (UE) function is critical to maintaining independence. Better understanding of UE involvement in MS will provide necessary information to prioritize the design and selection of future interventions. The goal of the proposed project is to characterize UE involvement in a population of...
What is the current status of trial NCT02398149?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2013-10. Estimated completion is 2016-10.
What conditions does trial NCT02398149 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
Who is sponsoring clinical trial NCT02398149?
This trial is sponsored by Mount Sinai Rehabilitation Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02398149 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.